153 related articles for article (PubMed ID: 11259558)
1. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
Yang JJ; Yin JH; Yang DI
Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosoglutathione and hypoxia-inducible factor-1 confer chemoresistance against carbamoylating cytotoxicity of BCNU in rat C6 glioma cells.
Yang DI; Chen SD; Yin JH; Hsu CY
Ann N Y Acad Sci; 2005 May; 1042():229-34. PubMed ID: 15965067
[TBL] [Abstract][Full Text] [Related]
5. NO-mediated chemoresistance in C6 glioma cells.
Yang DI; Yin JH; Mishra S; Mishra R; Hsu CY
Ann N Y Acad Sci; 2002 May; 962():8-17. PubMed ID: 12076959
[TBL] [Abstract][Full Text] [Related]
6. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
[TBL] [Abstract][Full Text] [Related]
7. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
9. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Zhang RX; Dougherty DV; Rosenblum ML
Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
[TBL] [Abstract][Full Text] [Related]
10. Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model.
Yamaguchi S; Bell HS; Shinoda J; Holmes MC; Wharton SB; Whittle IR
Br J Neurosurg; 2002 Dec; 16(6):567-72. PubMed ID: 12617238
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
[TBL] [Abstract][Full Text] [Related]
12. Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production.
Isakovic A; Harhaji L; Dacevic M; Trajkovic V
Eur J Pharmacol; 2008 Sep; 591(1-3):106-13. PubMed ID: 18606162
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells.
Shinoda J; McLaughlin KE; Bell HS; Swaroop GR; Yamaguchi S; Holmes MC; Whittle IR
Glia; 2003 Apr; 42(1):68-76. PubMed ID: 12594738
[TBL] [Abstract][Full Text] [Related]
14. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
15. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
Park SJ; Kaye AH; Hill JS
J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
[TBL] [Abstract][Full Text] [Related]
17. In vivo detection of inducible nitric oxide synthase in rodent gliomas.
Towner RA; Smith N; Doblas S; Garteiser P; Watanabe Y; He T; Saunders D; Herlea O; Silasi-Mansat R; Lupu F
Free Radic Biol Med; 2010 Mar; 48(5):691-703. PubMed ID: 20034558
[TBL] [Abstract][Full Text] [Related]
18. Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
Stojković S; Podolski-Renić A; Dinić J; Stanković T; Banković J; Hadžić S; Paunović V; Isaković A; Tanić N; Pešić M
Exp Cell Res; 2015 Jul; 335(2):248-57. PubMed ID: 26026740
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
Badn W; Hegardt P; Fellert MA; Darabi A; Esbjörnsson M; Smith KE; Janelidze S; Salford LG; Visse E; Siesjö P
Scand J Immunol; 2007 Mar; 65(3):289-97. PubMed ID: 17309784
[TBL] [Abstract][Full Text] [Related]
20. Expression of inducible nitric oxide synthase in smooth muscle cells from rat penile corpora cavernosa.
Hung A; Vernet D; Xie Y; Rajavashisth T; Rodríguez JA; Rajfer J; González-Cadavid NF
J Androl; 1995; 16(6):469-81. PubMed ID: 14959705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
